BUZZ-Salix Pharma Ltd: Valeant close to takeover bid - source

Fri Feb 20, 2015 10:30am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Drugmaker's shares up 4 pct at $156.90

** Canada's Valeant Pharmaceuticals International Inc could acquire bowel drug maker Salix for around $160 per share as early as next week, Reuters reported on Friday, citing a source

** Valeant's U.S.-listed stock climbs as much as 3.1 pct to record high of $174.43; Canadian shares up as much as 3.4 pct to life high of C$218.57

** Reuters exclusively reported last week that Endo International Plc had expressed interest in buying Salix a number of times, but had been rebuffed

** Britain's Shire Plc is also keen on Salix, sources had told Reuters earlier

** Up to Thursday's close, stock had risen more than 19 pct since Jan. 28, when Salix announced it was restating its results for the past seven quarters